Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Autografting

Autologous hematopoietic stem cell transplants that utilize total body irradiation can safely be carried out entirely on an outpatient basis

Abstract

Outpatient hematopoietic stem cell transplants (HSCT) are usually performed in patients receiving minimally mucotoxic preparative regimens; total body irradiation (TBI)-based regimens typically are excluded. To improve resource utilization and patient satisfaction, we developed a totally outpatient HSCT program for TBI regimens and compared outcomes for our first 100 such transplants to 32 performed as in-patients during the same interval, for caregiver or financial reasons. Symptoms were managed predominately with oral agents; pain management consisted of transdermal fentanyl and oral morphine solution. Except for more unmarried in-patients, the two groups were matched. Time to engraftment, severity of mucositis and transplant duration were identical for the two groups. Twenty-seven of the outpatients were admitted (median-6 days), primarily for progressing infection. Thus 92% of all transplant days were outpatient. There were no septic episodes or hospital admissions for pain management. There were no deaths to day 30 in either group and 100-day survival was identical. There was a mean cost savings of $16 000 per outpatient transplant and outpatient patient/caregiver quality of life was similar to that reported for in-patients. Patients undergoing severely mucotoxic regimens can be safely transplanted in an outpatient setting with a significant cost saving, with no increase in morbidity or mortality.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Dix SP, Geller RB . High-dose chemotherapy with autologous stem cell rescue in the outpatient setting. Oncology 2000; 14: 171–185.

    CAS  PubMed  Google Scholar 

  2. Gonzalez-Ryan L, Haut PR, Coyne K, Syckle KV, Duerst R, Haro D et al. Developing a pediatric outpatient transplantation program. The Children's Memorial Hospital experience. Front Biosci 2001; 6: 1–5.

    Article  Google Scholar 

  3. Corcoran-Buchsel P, Parchem C . Ambulatory care of the bone marrow transplant patient. Semin Oncol Nursing 1988; 4: 41–46.

    Article  CAS  Google Scholar 

  4. Seropian S, Nadkarni R, Jillella AP, Salloum E, Burtness B, Hu GL et al. Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: outpatient treatment is a viable option. Bone Marrow Transplant 1999; 23: 599–605.

    Article  CAS  PubMed  Google Scholar 

  5. Meisenberg BR, Ferran K, Hollenbach K, Brehm T, Jollon J, Piro LD . Reduced charges and costs associated with outpatient autologous stem cell transplantation. Bone Marrow Transplant 1998; 21: 927–932.

    Article  CAS  PubMed  Google Scholar 

  6. Coleman EA, Loon SK, Mattox SG, O’Sullivan P . Symptom management and successful outpatient transplantation for patients with multiple myeloma. Cancer Nurs 2002; 25: 452–460.

    Article  PubMed  Google Scholar 

  7. Ferrara F, Palmieri S, Viola A, Copia C, Schiavone EM, De Simone M et al. Outpatient-based peripheral blood stem cell transplantation for patients with multiple myeloma. Hematol J 2004; 5: 222–225.

    Article  PubMed  Google Scholar 

  8. Jagannath S, Vesole DH, Zhang M, Desikan KR, Copelan N, Jagannath M et al. Feasibility and cost-effectiveness of out-patient transplants in multiple myeloma. Bone Marrow Transplant 1997; 20: 445–450.

    Article  CAS  PubMed  Google Scholar 

  9. Grimm PM, Zawacki KL, Mock V, Krumm S, Frink BB . Caregiver responses and needs. An ambulatory bone marrow transplant model. Cancer Practice 2000; 8: 120–128.

    Article  CAS  PubMed  Google Scholar 

  10. Stiff PJ, Koester AR, Weidner MK, Dvorak K, Fisher RI . Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethylstarch without controlled-rate freezing. Blood 1987; 70: 974–978.

    CAS  PubMed  Google Scholar 

  11. Derogatis LR, Derogatis MF . Pais & PAIS-SR: Administration, Scoring & Procedures Manual-I. Clinical Psychometric Research: Baltimore, MD, 1990.

    Google Scholar 

  12. Smilkstein G . The family APGAR: a proposal for a family function test and its use by physicians. J Family Practice 1978; 6: 1231–1239.

    CAS  Google Scholar 

  13. Montgomery RJV, Gonyea JG, Hooyman NR . Caregiving and the experience of subjective and objective burden. Family Relat 1985; 34: 19–26.

    Article  Google Scholar 

  14. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912–2919.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Bredeson C, Perry G, Martens C, McDiarmid S, Bence-Bruckler I, Atkins H et al. Outpatient total body irradiation as a component of a comprehensive outpatient transplant program. Bone Marrow Transplant 2002; 29: 667–671.

    Article  CAS  PubMed  Google Scholar 

  16. Dagher R, Robertson KA, Lucas KG, Emmanuel D, Smith FO . Outpatient total body irradiation for pediatric patients undergoing stem cell transplantation. Bone Marrow Transplant 1997; 19: 1065–1067.

    Article  CAS  PubMed  Google Scholar 

  17. Hermann RP, Trent M, Cooney J, Cannell PK . Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant 1999; 24: 1213–1217.

    Article  Google Scholar 

  18. Westermann AM, Holtkamp MM, Linthorst GA, van Leeuwen L, Willemese EJ, van Dijk WC et al. At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies. Ann Oncol 1999; 10: 511–517.

    Article  CAS  PubMed  Google Scholar 

  19. Siston AK, List MA, Daugherty CK, Banik DM, Menke C, Cornetta K et al. Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation. Bone Marrow Transplant 2001; 27: 1181–1188.

    Article  CAS  PubMed  Google Scholar 

  20. Foxall MJ, Gaston-Johansson F . Burden and health outcomes of family caregivers of hospitalized bone marrow transplant patients. J Advanced Nursing 1996; 24: 915–923.

    Article  CAS  Google Scholar 

  21. Rizzo JD, Vogelsang GB, Krumm S, Frink B, Mock V, Bass EB . Out-patient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting? J Clin Oncol 1999; 17: 2811–2818.

    Article  CAS  PubMed  Google Scholar 

  22. Selby GB, Ali LI, Carter TH, Veseley S, Roy V . The influence of health insurance on outcomes of related-donor hematopoietic stem cell transplantation for AML and CML. Biol Blood Marrow Transplant 2001; 7: 576.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P Stiff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stiff, P., Mumby, P., Miler, L. et al. Autologous hematopoietic stem cell transplants that utilize total body irradiation can safely be carried out entirely on an outpatient basis. Bone Marrow Transplant 38, 757–764 (2006). https://doi.org/10.1038/sj.bmt.1705525

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705525

Keywords

This article is cited by

Search

Quick links